title: [The application of UHF therapy for the prevention of complications of specific antiblastoma therapy in the patients presenting with III-IV stage lung cancer].
abstract: One of the complications of specific antiblastoma therapy in the patients presenting with malignant neoplasms is the suppressed functional activity of blood neutrophil granulocytes. The results of clinical and experimental investigations suggest the enhanced enzymatic activity of neutrophils and lymphocytes under effect of ultrahigh-frequency electromagnetic radiation (UHF EMR). Our study has demonstrated that UHF EMR with a frequency selected on an individual basis in the range from 59 to 63 GHz exerts the protective action on the function and metabolism of blood neutrophils exposed to the damaging action of gamma-radiation in the patients presenting with lung cancer. Moreover, it allows the severity of local and systemic complications of specific antiblastoma chemo- and radiotherapy in these patients to be reduced.
authors.forename: N B
authors.initials: NB
authors.lastname: Kolmatsuĭ
authors.forename: E F
authors.initials: EF
authors.lastname: Levitskiĭ
authors.forename: O E
authors.initials: OE
authors.lastname: Golosova
authors.forename: I B
authors.initials: IB
authors.lastname: Pyzhova
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood / Q000473:pathology / Q000628:therapy*; D008872:Microwaves / Q000627:therapeutic use*; D009367:Neoplasm Staging; D009504:Neutrophils / Q000187:drug effects / Q000528:radiation effects; D018202:Pulmonary Blastoma / Q000097:blood / Q000473:pathology / Q000628:therapy*; D011878:Radiotherapy / Q000009:adverse effects* / Q000379:methods; D016896:Treatment Outcome